Clinical Trial Update: Phase III Trial of Dantonic® (T89) Capsule to Prevent and Treat Stable Angina [Phase 3]

View source ↗

Summary

Phase III trial of Dantonic (T89) Capsule for prevention and treatment of stable angina has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Drugs mentioned

• Dantonic

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Angina Pectoris | Phase 3 | Status: COMPLETED